Beijing Foyou Pharma CO.,LTD (SHA:601089)

SHA:601089 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	551.98	634.36	794.07	2,531	2,541	434.69
Trading Asset Securities	1,591	1,429	1,579	-	-	100
Cash & Short-Term Investments	2,143	2,063	2,373	2,531	2,541	534.69
Cash Growth	3.63%	-13.06%	-6.23%	-0.41%	375.27%	66.97%
Accounts Receivable	401.17	522.56	452.08	346.13	396.47	337.99
Other Receivables	93.68	1.42	1.2	100.23	74.77	57.66
Receivables	494.85	523.98	453.28	446.37	471.24	395.65
Inventory	455.74	412.66	347.56	307.42	339.1	324
Other Current Assets	43.89	52.7	27.26	44.14	20.79	25.08
Total Current Assets	3,137	3,053	3,201	3,329	3,372	1,279
Property, Plant & Equipment	1,656	1,690	1,426	983.41	779.77	721.73
Other Intangible Assets	131.16	139.79	139.21	150.2	142.61	144.24
Long-Term Deferred Tax Assets	5.05	4.39	3.31	2.81	4.72	4.39
Long-Term Deferred Charges	6.67	13	21.82	22.92	17.65	0.33
Other Long-Term Assets	9.97	24.37	25.34	59.71	4.86	3.08
Total Assets	4,946	4,924	4,817	4,548	4,322	2,153

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	280.66	258.49	286.76	132.18	143.51	129.77
Accrued Expenses	143.6	643.22	676.84	607.02	598.17	472.26
Short-Term Debt	-	-	40.03	55.05	40.05	70.09
Current Portion of Long-Term Debt	-	-	-	4.95	4.95	7.01
Current Portion of Leases	10.61	16.76	14.33	19.66	16.26	10.56
Current Income Taxes Payable	42.6	10.85	25.83	19.29	39.65	17.34
Current Unearned Revenue	54.19	23.88	36.59	39.74	80.96	42.82
Other Current Liabilities	503.66	98.1	109.55	120.48	129.46	116.64
Total Current Liabilities	1,035	1,051	1,190	998.38	1,053	866.48
Long-Term Debt	-	-	-	12.37	17.33	7.28
Long-Term Leases	2.01	9	20.79	32.26	44.33	43.06
Long-Term Unearned Revenue	49.12	49.06	34.49	10.02	9.5	4.14
Long-Term Deferred Tax Liabilities	24.88	21.79	15.33	18.22	18.85	16.9
Total Liabilities	1,111	1,131	1,261	1,071	1,143	937.86

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	480	480	480	480	480	360
Additional Paid-In Capital	1,662	1,662	1,662	1,662	1,662	146.47
Retained Earnings	1,843	1,803	1,567	1,314	1,017	686.08
Treasury Stock	-176.19	-176.19	-176.19	-	-	-
Comprehensive Income & Other	10.02	10.39	10.98	12.34	15.1	18.94
Total Common Equity	3,819	3,779	3,545	3,468	3,174	1,211
Minority Interest	16.12	13.42	11.53	8.12	4.55	3.83
Shareholders' Equity	3,835	3,793	3,556	3,477	3,179	1,215
Total Liabilities & Equity	4,946	4,924	4,817	4,548	4,322	2,153

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	12.62	25.76	75.16	124.3	122.92	137.99
Net Cash (Debt)	2,130	2,037	2,298	2,407	2,418	396.7
Net Cash Growth	4.47%	-11.34%	-4.51%	-0.49%	509.62%	67.76%
Net Cash Per Share	4.67	4.34	4.89	5.02	5.73	1.10
Filing Date Shares Outstanding	468	468	468	480	480	360
Total Common Shares Outstanding	468	468	468	480	480	360
Working Capital	2,102	2,001	2,011	2,330	2,319	412.94
Book Value Per Share	8.16	8.08	7.57	7.23	6.61	3.37
Tangible Book Value	3,688	3,640	3,405	3,318	3,032	1,067
Tangible Book Value Per Share	7.88	7.78	7.28	6.91	6.32	2.96
Buildings	-	1,288	523.07	520.3	506.03	443.93
Machinery	-	911.52	609.64	558.75	511.19	416.4
Construction In Progress	-	19.27	719.15	255.66	46.72	100.06

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error